Provided by Tiger Trade Technology Pte. Ltd.

Cummins

538.61
-18.1434-3.26%
Volume:633.46K
Turnover:340.22M
Market Cap:74.35B
PE:27.53
High:542.55
Open:531.02
Low:526.49
Close:556.75
52wk High:737.76
52wk Low:400.72
Shares:138.04M
Float Shares:137.01M
Volume Ratio:0.91
T/O Rate:0.46%
Dividend:8
Dividend Rate:1.49%
EPS(TTM):19.56
EPS(LYR):20.50
ROE:21.11%
ROA:7.00%
PB:5.79
PE(LYR):26.27

Loading ...

Cummins (CMI) Could Be 15% Undervalued Following Record Q2 Results And Higher Guidance

Simply Wall St.
·
Aug 13

Norway's AutoStore Q2 Revenue Beats Estimates on Strong Order Intake

Reuters
·
Aug 13

Canada's Liberty Gold Q2 Net Income Turns Positive on Asset Sale

Reuters
·
Aug 13

Canada's Pollard Banknote Q2 Revenue Rises on Higher Ticket Volumes, Increased Prices

Reuters
·
Aug 13

Kimball Electronics Q4 Revenue Slightly Misses Estimates

Reuters
·
Aug 13

Singapore's AP Oil International H1 Revenue Rises on Trading Segment Growth

Reuters
·
Aug 12

Singapore's GSH Corp Half-Year Revenue Falls 32% on Weaker Property Sales

Reuters
·
Aug 12

Intelligent Protection Management Q2 Revenue Rises

Reuters
·
Aug 12

TransAct Q2 Net Loss Narrows on Higher Gross Profit; Reviews Casino Unit

Reuters
·
Aug 12

QuickLogic Q2 Revenue Rises Less than Expected

Reuters
·
Aug 12

Denmark's H+H International Q2 Organic Revenue Rises 6%

Reuters
·
Aug 11

Evercore ISI Adjusts Price Target on Cummins to $782 From $845, Keeps Outperform Rating

MT Newswires Live
·
Aug 11

Mahindra Appoints Shveta Arya as Group Chief Strategy Officer

Reuters
·
Aug 11

Cummins Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 11

Brookdale Returns to Q2 Profit as RevPAR Rises

Reuters
·
Aug 11

Kopin Q2 Revenue Rises 51% on Government Grants, Higher Defense Sales

Reuters
·
Aug 11

Ireland's Theravance Biopharma Q2 Revenue Rises 11% but Misses Estimates

Reuters
·
Aug 10

Canada's Stingray Q1 Revenue Beats Estimates but Margins Weigh on Profit

Reuters
·
Aug 10

Press Release: Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
Aug 08

Gyre Therapeutics Q2 Revenue Beats Estimates on Higher Etuary Sales Volumes

Reuters
·
Aug 07